1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
View analysts' price targets and recommendations, and compare them with competitors.
$17.50
Analysts expect the stock price to increase by 1036.36%.
Hold
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
96.03M
Revenue has decreased from the previous period.
-4.06%
Revenue growth rate is unchanged from the previous period.
-9.36M
EBITDA has increased from the previous period.
-9.75%
EBITDA margin is unchanged from the previous period.
-11.42M
EBIT has increased from the previous period.
-11.89%
EBIT margin is unchanged from the previous period.
2.06M
Depreciation has decreased from the previous period.
20.86M
Total cash has decreased from the previous period.
21.72%
Cash percentage is unchanged from the previous period.
23.87M
Receivables have decreased from the previous period.
24.86%
Receivables percentage is unchanged from the previous period.
15.46M
Inventories have decreased from the previous period.
16.10%
Inventory percentage is unchanged from the previous period.
12.19M
Accounts payable has decreased from the previous period.
12.69%
Payables percentage is unchanged from the previous period.
-1.26M
Capital expenditure has decreased from the previous period.
-1.31%
CapEx percentage is unchanged from the previous period.
6.97%
WACC is unchanged from the previous period.
7.17%
Cost of equity is unchanged from the previous period.
10.60%
Cost of debt is unchanged from the previous period.
0.67
Beta is unchanged from the previous period.
75.35M
Diluted shares outstanding is unchanged from the previous period.
153.06M
Total debt is unchanged from the previous period.
125.83M
Total equity is unchanged from the previous period.
278.89M
Total capital is unchanged from the previous period.
54.88%
Debt weighting is unchanged from the previous period.
45.12%
Equity weighting is unchanged from the previous period.
-7.33M
EBIAT has increased from the previous period.
-5.38M
UFCF has increased from the previous period.
1.00%
Long-term growth rate is unchanged from the previous period.
-83.85M
Terminal value is unchanged from the previous period.
-49.12M
Enterprise value is unchanged from the previous period.
139.68M
Net debt is unchanged from the previous period.
-188.80M
Equity value is unchanged from the previous period.
-2.51
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
554.00M
The estimated revenue has increased from the previous period.
-54.01M
The estimated EBITDA has decreased from the previous period.
0.36
The estimated EPS has increased from the previous period.
27.13M
The estimated net income has increased from the previous period.
-65.87M
The estimated EBIT has decreased from the previous period.
250.79M
The estimated SG&A expenses have increased from the previous period.
